Title: Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle.
Journal: Cell metabolism 20140603
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.
Journal: Gynecologic oncology 20120901
Title: Neoadjuvant treatments for triple-negative breast cancer (TNBC).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20120801
Title: Current and emerging targeted therapies for metastatic breast cancer.
Journal: Cancer 20120615
Title: Dissecting the heterogeneity of triple-negative breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120520
Title: Re: potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer.
Journal: Journal of the National Cancer Institute 20120502
Title: Nickel-catalysed aromatic Finkelstein reaction of aryl and heteroaryl bromides.
Journal: Chemical communications (Cambridge, England) 20120425
Title: [PARP inhibitors and breast cancer: update and perspectives].
Journal: Bulletin du cancer 20120401
Title: Drug candidates derailed in case of mistaken identity.
Journal: Nature 20120328
Title: Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120315
Title: Present status and problems on molecular targeted therapy of cancer.
Journal: Cancer research and treatment : official journal of Korean Cancer Association 20120301
Title: Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120115
Title: Basal breast cancer: a complex and deadly molecular subtype.
Journal: Current molecular medicine 20120101
Title: Ovarian cancer: opportunity for targeted therapy.
Journal: Journal of oncology 20120101
Title: BRCAness profile of sporadic ovarian cancer predicts disease recurrence.
Journal: PloS one 20120101
Title: Molecular basis of triple negative breast cancer and implications for therapy.
Journal: International journal of breast cancer 20120101
Title: Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer.
Journal: International journal of breast cancer 20120101
Title: Major clinical research advances in gynecologic cancer in 2011.
Journal: Journal of gynecologic oncology 20120101
Title: Advances in using PARP inhibitors to treat cancer.
Journal: BMC medicine 20120101
Title: Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.
Journal: Journal of oncology 20120101
Title: Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene.
Journal: PloS one 20120101
Title: Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone.
Journal: Journal of oncology 20120101
Title: The first European interdisciplinary ewing sarcoma research summit.
Journal: Frontiers in oncology 20120101
Title: Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer.
Journal: Journal of the National Cancer Institute 20111207
Title: The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.
Journal: Therapeutic advances in medical oncology 20111101
Title: Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.
Journal: Cancer science 20111001
Title: PARP inhibitors--current status and the walk towards early breast cancer.
Journal: Breast (Edinburgh, Scotland) 20111001
Title: DNA-damaging therapies emerging as possible triple-negative breast cancer therapies.
Journal: Oncology (Williston Park, N.Y.) 20111001
Title: PARP inhibitors: its role in treatment of cancer.
Journal: Chinese journal of cancer 20110701
Title: Novel agents and future directions for refractory breast cancer.
Journal: Seminars in oncology 20110601
Title: Iniparib in metastatic triple-negative breast cancer.
Journal: The New England journal of medicine 20110505
Title: Few positives for triple-negative breast cancer.
Journal: Journal of the National Cancer Institute 20110406
Title: Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.
Journal: Anticancer research 20110401
Title: Triple negative breast cancer: unmet medical needs.
Journal: Breast cancer research and treatment 20110201
Title: Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
Journal: The New England journal of medicine 20110120
Title: PARP and cancer--if it's broke, don't fix it.
Journal: The New England journal of medicine 20110120
Title: PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy.
Journal: Acta clinica Belgica 20110101
Title: Promising molecular targeted therapies in breast cancer.
Journal: Indian journal of pharmacology 20110101
Title: Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.
Journal: Cancer management and research 20110101
Title: Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells.
Journal: BMC pharmacology 20110101
Title: Drug therapy for hereditary cancers.
Journal: Hereditary cancer in clinical practice 20110101
Title: Management options in triple-negative breast cancer.
Journal: Breast cancer : basic and clinical research 20110101
Title: Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?
Journal: Breast cancer research : BCR 20110101
Title: Tips and tricks in triple-negative breast cancer: how to manage patients in real-life practice?
Journal: Ecancermedicalscience 20110101
Title: Triple-negative breast cancer: adjuvant therapeutic options.
Journal: Chemotherapy research and practice 20110101
Title: [PARP inhibitors to treat triple negative breast cancer].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20101201
Title: Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer.
Journal: IDrugs : the investigational drugs journal 20100901
Title: Small-molecule PARP modulators--current status and future therapeutic potential.
Journal: Current opinion in drug discovery & development 20100901
Title: Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms.
Journal: Journal of the National Cancer Institute 20100804
Title: Treatment options for patients with triple-negative breast cancer.
Journal: Journal of hematology & oncology 20100101
Title: Directed therapy of subtypes of triple-negative breast cancer.
Journal: The oncologist 20100101
Title: Enzymatic mechanism of the tumoricidal action of 4-iodo-3-nitrobenzamide.
Journal: Molecular medicine reports 20090101
Title: Anti-cancer action of 4-iodo-3-nitrobenzamide in combination with buthionine sulfoximine: inactivation of poly(ADP-ribose) polymerase and tumor glycolysis and the appearance of a poly(ADP-ribose) polymerase protease.
Journal: Biochemical pharmacology 20020201
Title: Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamide. Metabolic reduction to the 3-nitroso derivative and induction of cell death in tumor cells in culture.
Journal: Biochemical pharmacology 19950825
Title: Liu X, et al. Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. Clin Cancer Res. 2012 Jan 15;18(2):510-23.
Title: Yin S, et al. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS One. 2017 Aug 17;12(8):e0183578.
Title: Ma W, et al. Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6590-5.
